ArticleCureus2025
A Streamlined Treatment Algorithm for Allergic Rhinitis in the Arab Region: Expert Panel Opinion.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allergic rhinitis is the strongest independent predictor of obstructive sleep apnea severity in preschool children.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis (AR) is a prevalent atopic condition that is frequently misdiagnosed, mistreated, or overlooked, despite its high prevalence and significant economic burden. Pharmacotherapy effectively controls symptoms in the majority of cases; however, the current local guidelines and recommendations are ambiguous regarding the initiation and cessation of combined antihistamines and intranasal corticosteroids treatment. Additionally, guidelines do not specify the duration of AR therapy or identify cases eligible for combination therapy. In contrast, the current era emphasizes personalized medicine, which considers genetic variants that may clinically alter the tolerance and intended outcome of specific drugs. Moreover, there has been a noticeable surge in the number of individuals affected by AR in the Arab region. A systematic treatment algorithm tailored to the Arab region's population is urgently needed. This consensus outlines the recommendations of experts from three scientific meetings that gathered specialists in otolaryngology, pediatrics, and immuno-allergology from Egypt, Tunisia, the Kingdom of Saudi Arabia, and the United Arab Emirates. The expert panel opinion encompassed pre-meeting surveys followed by discussions about diversified topics related to AR management in the Arab region, including AR diagnosis and disease characteristics, patient profiling, and conventional and advanced treatment options. The experts developed a streamlined algorithm to enhance decision-making for AR treatment in Arab countries, based on discussions and a comprehensive literature review. To our knowledge, this manuscript presents the first region-specific, consensus-based management algorithm tailored to the Arab region, addressing unique local considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.